-
Manufacturing, Supply Chain & Infrastructure3 weeks agoKagan, Soai Win 2026 Nobel Prize in Chemistry for Discoveries Related to Asymmetric Organic Synthesis
Henri Kagan, PhD, and Kenso Soai, PhD, shared this year's award for the discovery of non-linear effects and autocatalysis in asymmetric organic synthesis respectively. The post...
-
Capital, M&A & Industry Strategy4 weeks agoSensible Biotechnologies Raises $47M to Expand Next-Generation Platform for mRNA Medicines
Sensible Biotechnologies raised $47 million to scale VECTOR, its integrated platform pairing AI-enabled mRNA design with manufacturing of naturally modified mRNA in living cells, aiming to...
-
AI, Machine Learning & Computational Biology4 weeks agoTalus Bio’s Structure-Free AI Model Targets Unstructured Proteins in Their Native Cellular Context
Intrinsically disordered proteins have resisted structure-based drug discovery because they lack a stable fold to model. Talus Bio's structure-free AI model sidesteps that limitation, targeting these...
-
AI, Machine Learning & Computational Biology1 month agoGinkgo Datapoints, Apheris Announce Founding Members of Antibody Developability Consortium
The consortium aims to address antibody development bottlenecks by creating standardized datasets and AI models that support earlier risk detection and more informed candidate selection. The...
-
Clinical Trials & Development1 month agoPalomar Labs Spins Out Ariadne Bio to Advance Non-Hallucinogenic Therapy for Parkinson’s Apathy
Backed by preclinical data and funding from The Michael J. Fox Foundation, Ariadne Bio is advancing AB-300, a serotonin 2A receptor agonist, as a potential treatment...
-
Drug Discovery & Therapeutics2 months agoBone Marrow-on-a-Chip Model Offers New Window Into Immune Cell Development and Behavior
By reproducing elements of human bone marrow on a chip, scientists have created a new tool that will help them gain new insights into how immune...
FDA Grants Accelerated Approval to Voceryq (doruxapapogene ralaplasmid and lalikinogene sifuplasmid-gxfd) for Recurrent Respiratory Papillomatosis
Opentrons Raises $40M in Series E to Expand Its Robotics, Software, Data Infrastructure
100 Million-Cell AI-Ready Dataset with Single-Cell and Proteomic Data Created by Parse and Nomic
Novartis buys Synnovation’s PI3Kα inhibitors for $3 billion
Novartis to pay $2B upfront to take next-gen PI3Kα inhibitor from Synnovation
